ArticleTherapeutic drug monitoring2016

A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function.

James Ermer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.